Mayo Clinic's Stem Cell Research Takes to Space
A new mission aboard SpaceX CRS-29, launching from NASA's Kennedy Space Center in Cape Canaveral, Florida, on January 30, 2024, …
News
This Collaboration Aims to Achieve Infinite Recyclability of Plastics
Basecamp has announced their expanded collaboration with Protein Evolution to help eliminate global polyurethane and polyamide waste, which account for a …
In an Industry First, Veeva Migrates Study Portfolio of Top 20 Biopharmas to Vault EDC
Veeva Systems, a prominent player in cloud-based software for the global life sciences industry, has successfully migrated a significant portfolio …
Innovative Approach to Combat Arthritis: Mesenbio's Stem Cell Therapy
Mesenbio, a pioneering biotechnology firm emerging from the University of York, has recently secured a significant £1.4 million investment. This …
A Proof-of-Concept Study Towards Novel ALS Therapy
Verge Genomics, a clinical-stage biotechnology company, has just initiated a Phase 1b proof-of-concept study for VRG50635, a drug developed for …
Xcell Biosciences and ElevateBio Forge Partnership to Enhance Cell and Gene Therapy Development
Xcell Biosciences, Inc., a notable company in the field of cell and gene therapy applications, has recently unveiled a strategic …
Isomorphic Labs Announces Collaborations with Eli Lilly and Novartis for AI-Driven Drug Discovery
Isomorphic Labs, a digital biology company specializing in AI applications, has entered into two distinct research collaborations with Eli Lilly …
Exploring a Novel Approach to Treat Primary Ciliary Dyskinesia: The RCT1100 Study
ReCode Therapeutics, a leader in genetic medicines, is pioneering a promising avenue in the treatment of primary ciliary dyskinesia (PCD) …
Menarini Group and Insilico Medicine Forge Partnership for Novel Cancer Therapy Development
In a new development in oncology, the Menarini Group and Insilico Medicine have announced an exclusive global licensing agreement. This …
C4X Discovery: Advancing Drug Discovery with NRF2 Activator Program
C4X Discovery Holdings plc (AIM: C4XD), a drug discovery company, recently announced a significant milestone in its partnership with AstraZeneca. …
InVivo Biosystems Raises $3M for CRISPR Research and Welcomes New Board Chairman
InVivo Biosystems, operating in the realm of CRISPR-edited animal models for biomedical research, has recently embarked on a new phase …
Bioptimus: Pioneering LLMs in Biotechnology
Executives from the French AI drug discovery company Owkin have embarked on a new venture, launching Bioptimus, a startup dedicated …